Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-24

Evolving evidence based treatment strategies for infantile hyperinsulinism using clinical, genetic and cell biological insights into a heterogenous disease

Objective

Infantile hyperinsulinism (HI) is a rare devastating heterogeneous genetic disease. Germ line or somatic mutations in one of four genes (resulting in loss / reduction of ATP dependent potassium currents in the pancreatic b-cell membrane) are founding 50 % of individuals. Overall 35% of patients have a somatic mutation within an abnormal focus of pancreas ( foHI ). The genetic basis in other patients is obscure. This proposal will
(a) screen new candidate genes identified through study of clinical phenotype and b-cell biology in vitro;
b) evolve strategies to identify foHI early and facilitate early specialist surgery in supra-regional surgical centres;
(c) critically evaluate / develop new treatments for non-foHI;
(d)establish a multinational patient / genetic database;
(e) establish and cryopreserve HI b-cell lines for future genetic manipulation and transplantation studies.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

You need to log in or register to use this function

Call for proposal

Data not available

Coordinator

UNIVERSITY COLLEGE LONDON
EU contribution
No data
Address
30,Guilford Street 30
WC1N 1EH LONDON
United Kingdom

See on map

Total cost
No data

Participants (12)